Clodronate Liposomes: Precision Macrophage Depletion Reag...

2026-01-20

Clodronate Liposomes enable targeted in vivo macrophage depletion, supporting advanced research in immune cell modulation and cancer immunotherapy. As a macrophage depletion reagent, this product offers robust, reproducible results in transgenic mouse and inflammation models. APExBIO’s K2721 kit is benchmarked for selectivity, tissue specificity, and compatibility with diverse administration routes.